Citation Impact
Citing Papers
Emergence of Epidemic Multidrug-Resistant Enterococcus faecium from Animal and Commensal Strains
2013
Immune Control of Tuberculosis by IFN-γ-Inducible LRG-47
2003 StandoutScience
Progression and Treatment Outcomes of Lung Disease Caused by Mycobacterium abscessus and Mycobacterium massiliense
2016 Standout
Microbiota in health and diseases
2022 Standout
Bronchial microbiome of severe COPD patients colonised by Pseudomonas aeruginosa
2014
Clinical Significance of a First Positive Nontuberculous Mycobacteria Culture in Cystic Fibrosis
2014
A systematic review of evidence on the links between patient experience and clinical safety and effectiveness
2013 Standout
Targeting microbial biofilms: current and prospective therapeutic strategies
2017 Standout
Interventions for the eradication of methicillin-resistantStaphylococcus aureus(MRSA) in people with cystic fibrosis
2013
A Comparison of Bayesian Methods for Haplotype Reconstruction from Population Genotype Data
2003 Standout
Candida and the paediatric lung
2009
Lumacaftor–Ivacaftor in Patients with Cystic Fibrosis Homozygous for Phe508delCFTR
2015 Standout
Molecular Characterization ofStenotrophomonas maltophiliaIsolates from Cystic Fibrosis Patients and the Hospital Environment
2009
Novel immunologic classification of aspergillosis in adult cystic fibrosis
2013
Adhesion to and biofilm formation on IB3-1 bronchial cells by Stenotrophomonas maltophilia isolates from cystic fibrosis patients
2010
Cystic fibrosis
2016 Standout
Measurement of Immunoglobulin G against Mycobacterial Antigen A60 in Patients with Cystic Fibrosis and Lung Infection Due to Mycobacterium abscessus
2004
Pseudomonas Aeruginosa: Resistance to the Max
2011 Standout
Prevention and treatment ofStaphylococcus aureusbiofilms
2015
Fate, activity, and impact of ingested bacteria within the human gut microbiota
2015
The Effectiveness of Mobile-Health Technology-Based Health Behaviour Change or Disease Management Interventions for Health Care Consumers: A Systematic Review
2013 Standout
Treatment of Mycobacterium avium-intracellulare complex Lung Disease With a Macrolide, Ethambutol, and Clofazimine
2003
Factors Affecting the Incidence of Stenotrophomonas maltophilia Isolation in Cystic Fibrosis
2002
Stenotrophomonas maltophilia: antimicrobial resistance and molecular typing of an emerging pathogen in a Turkish university hospital
2005
Predicting the Functional Effect of Amino Acid Substitutions and Indels
2012 Standout
Emerging bacterial pathogens and changing concepts of bacterial pathogenesis in cystic fibrosis
2015
Nontuberculous mycobacterial infection in young children with cystic fibrosis
2005
British Thoracic Society guidelines for the management of non-tuberculous mycobacterial pulmonary disease (NTM-PD)
2017 Standout
Stenotrophomonas maltophilia strains from cystic fibrosis patients: Genomic variability and molecular characterization of some virulence determinants
2010
Patient segregation and aggressive antibiotic eradication therapy can control methicillin-resistant Staphylococcus aureus at large cystic fibrosis centres
2010
Antibiotic resistance of bacterial biofilms
2010 Standout
Successful decolonization of meticillin-resistant Staphylococcus aureus in paediatric patients with cystic fibrosis (CF) using a three-step protocol
2006
Skeletal infections: microbial pathogenesis, immunity and clinical management
2022 Standout
Antibiotic Treatment of Multidrug-Resistant Organisms in Cystic Fibrosis
2003
Defining and combating antibiotic resistance from One Health and Global Health perspectives
2019
Bad Bugs Need Drugs: An Update on the Development Pipeline from the Antimicrobial Availability Task Force of the Infectious Diseases Society of America
2006 Standout
Clinical and Microbiologic Outcomes in Patients Receiving Treatment for Mycobacterium abscessus Pulmonary Disease
2011 Standout
Methicillin‐resistant Staphylococcus aureus in children with cystic fibrosis: An eradication protocol
2003
Chronic Mycobacterium abscessus infection and lung function decline in cystic fibrosis
2010 Standout
Early intervention and prevention of lung disease in cystic fibrosis: a European consensus
2004
Antimicrobial therapy for pulmonary pathogenic colonisation and infection by Pseudomonas aeruginosa in cystic fibrosis patients
2005
US Cystic Fibrosis Foundation and European Cystic Fibrosis Society consensus recommendations for the management of non-tuberculous mycobacteria in individuals with cystic fibrosis
2015
Serodiagnosis ofMycobacterium abscessuscomplex infection in cystic fibrosis
2015
US Cystic Fibrosis Foundation and European Cystic Fibrosis Society consensus recommendations for the management of non-tuberculous mycobacteria in individuals with cystic fibrosis: executive summary
2015
Fimbriae and adherence ofStenotrophomonas maltophiliato epithelial cells and to abiotic surfaces
2003
Microbiology and outcomes of community acquired pneumonia in non cystic-fibrosis bronchiectasis patients
2015
The role of short-chain fatty acids in microbiota–gut–brain communication
2019 Standout
Role of the gut microbiota in nutrition and health
2018 Standout
Cystic fibrosis genetics: from molecular understanding to clinical application
2014 Standout
Urban wastewater treatment plants as hotspots for antibiotic resistant bacteria and genes spread into the environment: A review
2013 Standout
Panton-Valentine leukocidin and biofilm production of Staphylococcus aureus isolated from respiratory tract
2013
Autophagy modulation as a potential therapeutic target for diverse diseases
2012 Standout
Recent Advances and Ongoing Challenges in the Diagnosis of Microbial Infections by MALDI-TOF Mass Spectrometry
2018
Influence of diet on the gut microbiome and implications for human health
2017 Standout
Call of the wild: antibiotic resistance genes in natural environments
2010 Standout
Non‐tuberculous mycobacteria in children with cystic fibrosis: Isolation, prevalence, and predictors
2009
Therapy of CF-Patients with Amitriptyline and Placebo - a Randomised, Double-Blind, Placebo-Controlled Phase IIb Multicenter, Cohort-Study
2013 Standout
Successful treatment of methicillin‐resistant Staphylococcus aureus pulmonary infection with linezolid in a patient with cystic fibrosis
2002
Nontuberculous mycobacteria
2013
In vitro susceptibility of Stenotrophomonas maltophilia isolates: comparison of disc diffusion, Etest and agar dilution methods
2004
Mycobacterium avium complex Pulmonary Disease in Patients Without HIV Infection
2004
Use of INNO-LIPA assay for rapid identification of mycobacteria
2003
Update on Key Emerging Challenges in Cystic Fibrosis
2014 Standout
Infection Control Recommendations for Patients With Cystic Fibrosis: Microbiology, Important Pathogens, and Infection Control Practices to Prevent Patient-to-Patient Transmission
2003
Nontuberculous Mycobacterial Infection in Hematopoietic Stem Cell and Solid Organ Transplant Recipients
2004
Fosfomycin for the treatment of multidrug-resistant, including extended-spectrum β-lactamase producing, Enterobacteriaceae infections: a systematic review
2009 Standout
Identification of genomic groups in the genusStenotrophomonasusinggyrBRFLP analysis
2003
Probiotic supplementation in children with cystic fibrosis—a systematic review
2016
Bacterial hypermutation in cystic fibrosis, not only for antibiotic resistance
2010
Diagnosis and Treatment of Adults with Community-acquired Pneumonia. An Official Clinical Practice Guideline of the American Thoracic Society and Infectious Diseases Society of America
2019 Standout
An Official ATS/IDSA Statement: Diagnosis, Treatment, and Prevention of Nontuberculous Mycobacterial Diseases
2007 Standout
Pathophysiology and Management of Pulmonary Infections in Cystic Fibrosis
2003 Standout
Nontuberculous Mycobacteria
2003
Staphylococcus aureus Infections: Epidemiology, Pathophysiology, Clinical Manifestations, and Management
2015 Standout
Genetic Dissection of Immunity to Mycobacteria: The Human Model
2002
Practice Guidelines for the Diagnosis and Management of Skin and Soft Tissue Infections: 2014 Update by the Infectious Diseases Society of America
2014 Standout
Mobile Genetic Elements Associated with Antimicrobial Resistance
2018 Standout
Development of Monocytes, Macrophages, and Dendritic Cells
2010 StandoutScience
Antimicrobial Susceptibilities of Unique Stenotrophomonas maltophilia Clinical Strains
2001
In Vitro Pharmacodynamics of Levofloxacin and Other Aerosolized Antibiotics under Multiple Conditions Relevant to Chronic Pulmonary Infection in Cystic Fibrosis
2009
Allergic Bronchopulmonary Aspergillosis
1999
The Hidden World within Plants: Ecological and Evolutionary Considerations for Defining Functioning of Microbial Endophytes
2015 Standout
Practice Guidelines for the Diagnosis and Management of Aspergillosis: 2016 Update by the Infectious Diseases Society of America
2016 Standout
Infection control recommendations for patients with cystic fibrosis: Microbiology, important pathogens, and infection control practices to prevent patient-to-patient transmission
2003
Clinical Practice Guideline for the Management of Candidiasis: 2016 Update by the Infectious Diseases Society of America
2015 Standout
Interventions for the eradication of meticillin-resistant Staphylococcus aureus (MRSA) in people with cystic fibrosis
2015
Interventions for enhancing medication adherence
2014 Standout
The Immune Response in Tuberculosis
2013 Standout
2007 Guideline for Isolation Precautions: Preventing Transmission of Infectious Agents in Health Care Settings
2007 Standout
Animal models of gastrointestinal and liver diseases. Animal models of cystic fibrosis: gastrointestinal, pancreatic, and hepatobiliary disease and pathophysiology
2015
Fosfomycin for the treatment of infections caused by Gram-positive cocci with advanced antimicrobial drug resistance: a review of microbiological, animal and clinical studies
2009
Biofilm-Related Infections: Bridging the Gap between Clinical Management and Fundamental Aspects of Recalcitrance toward Antibiotics
2014 Standout
Identification of simple arylfluorosulfates as potent agents against resistant bacteria
2021 StandoutNobel
The respiratory threat posed by multidrug resistant G ram‐negative bacteria
2017
Stenotrophomonas maltophilia: an Emerging Global Opportunistic Pathogen
2012 Standout
Community-Associated Methicillin-ResistantStaphylococcus aureus: Epidemiology and Clinical Consequences of an Emerging Epidemic
2010 Standout
Lung Infections Associated with Cystic Fibrosis
2002 Standout
Polymorphic Mutation Frequencies of Clinical and Environmental Stenotrophomonas maltophilia Populations
2010
Multicenter Cross-Sectional Study of Nontuberculous Mycobacterial Infections among Cystic Fibrosis Patients, Israel
2008
Antimicrobial Resistance in ESKAPE Pathogens
2020 Standout
Works of Luís Máiz being referenced
Antibióticos nebulizados en pacientes con fibrosis quística
2001
Allergic bronchopulmonary aspergillosis with low serum IgE levels in a child with cystic fibrosis
1997
Multidimensional approach to non-cystic fibrosis bronchiectasis: the FACED score
2013
Patógenos multirresistentes en la fibrosis quística
2002
Improvement of digestive health and reduction in proteobacterial populations in the gut microbiota of cystic fibrosis patients using a Lactobacillus reuteri probiotic preparation: A double blind prospective study
2014
High prevalence in cystic fibrosis patients of multiresistant hospital-acquired methicillin-resistant Staphylococcus aureus ST228-SCCmecI capable of biofilm formation
2008
Tratamiento antibiótico intravenoso domiciliario en las unidades de fibrosis quística de la Comunidad de Madrid
2004
Nontuberculous Mycobacteria in Patients with Cystic Fibrosis
2001
Diagnóstico y tratamiento de las bronquiectasias
2008
MALDI-TOF MS improves routine identification of non-fermenting Gram negative isolates from cystic fibrosis patients
2011
Serologic IgE Immune Responses Against Aspergillus fumigatus and Candida albicans in Patients With Cystic Fibrosis
2002
Antimicrobial susceptibility profile of molecular typed cystic fibrosis Stenotrophomonas maltophilia isolates and differences with noncystic fibrosis isolates
2003
Diagnosis and Treatment of Bronchiectasis
2008
Tratamiento antibiótico intravenoso domiciliario en las unidades de fibrosis quística de la Comunidad de Madrid
2004
Population Structure, Antimicrobial Resistance, and Mutation Frequencies of Streptococcus pneumoniae Isolates from Cystic Fibrosis Patients
2005
Estudio multicéntrico de prevalencia de micobacterias ambientales en pacientes con fibrosis quística
2008
Individual Patterns of Complexity in Cystic Fibrosis Lung Microbiota, Including Predator Bacteria, over a 1-Year Period
2017
Aerosolized vancomycin for the treatment of methicillin‐resistantStaphylococcus aureusinfection in cystic fibrosis
1998
Persistence and variability of Stenotrophomonas maltophilia in Cystic Fibrosis Patients, Madrid, 1991-1998
2001
Gut microbiota composition in cystic fibrosis patients: molecular approach and classical culture
2008
Nontuberculous Mycobacterial Infection in Patients With Cystic Fibrosis: A Multicenter Prevalence Study
2008